165 related articles for article (PubMed ID: 10589818)
1. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.
Mahns DA; Kelly C; McCloskey DI; Potter EK
J Auton Nerv Syst; 1999 Oct; 78(1):10-7. PubMed ID: 10589818
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
Mahns DA; Lacroix JS; Potter EK
J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sympathetic cholinergic vasodilatation by a selective NPY Y2 receptor agonist in the gracilis muscle of anaesthetised dogs.
Mahns DA; Revington ML; Runcie MJ; McCloskey DI; Potter EK
J Auton Nerv Syst; 1998 Jan; 68(1-2):14-20. PubMed ID: 9531441
[TBL] [Abstract][Full Text] [Related]
4. Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs.
Revington M; Lacroix JS; Potter EK
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):823-31. PubMed ID: 9457655
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
6. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
Lacroix JS; Ulman LG; Potter EK
Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
[TBL] [Abstract][Full Text] [Related]
7. A role for neuropeptide Y in rat iridial arterioles.
Newhouse MJ; Hill CE
Am J Physiol; 1997 Nov; 273(5):H2119-27. PubMed ID: 9374743
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
Oellerich WF; Malik KU
J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
[TBL] [Abstract][Full Text] [Related]
9. NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.
Moriya R; Shirakura T; Hirose H; Kanno T; Suzuki J; Kanatani A
Peptides; 2010 Apr; 31(4):671-5. PubMed ID: 19925840
[TBL] [Abstract][Full Text] [Related]
10. Evidence for two neuropeptide Y receptors mediating vasoconstriction.
Modin A; Pernow J; Lundberg JM
Eur J Pharmacol; 1991 Oct; 203(2):165-71. PubMed ID: 1666044
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
Serone AP; Wright CE; Angus JA
Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic and parasympathetic interaction in vascular and secretory control of salivary glands in anaesthetised dogs.
McCloskey MJ; Potter EK
Auton Neurosci; 2000 Oct; 84(1-2):50-7. PubMed ID: 11109989
[TBL] [Abstract][Full Text] [Related]
13. A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor.
Potter EK; Barden JA; McCloskey MJ; Selbie LA; Tseng A; Herzog H; Shine J
Eur J Pharmacol; 1994 May; 267(3):253-62. PubMed ID: 8088364
[TBL] [Abstract][Full Text] [Related]
14. Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs.
Potter EK; Tripovic D
Exp Brain Res; 2006 Aug; 173(2):346-52. PubMed ID: 16733694
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of vasoconstriction and Ca2+ currents mediated by neuropeptide Y Y2 receptors.
Lewis CJ; Evans RJ; Neild TO
J Smooth Muscle Res; 1999; 35(5-6):147-56. PubMed ID: 10733151
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
17. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
Modin A; Pernow J; Lundberg JM
Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
[TBL] [Abstract][Full Text] [Related]
18. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
19. Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions.
Smith-White MA; Hardy TA; Brock JA; Potter EK
Br J Pharmacol; 2001 Feb; 132(4):861-8. PubMed ID: 11181427
[TBL] [Abstract][Full Text] [Related]
20. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
